4.1 Resolution of symptoms post‐treatment (ITT analysis) |
3 |
795 |
Odds Ratio (M‐H, Random, 95% CI) |
0.70 [0.49, 0.99] |
4.1.1 Adults |
2 |
562 |
Odds Ratio (M‐H, Random, 95% CI) |
0.75 [0.46, 1.22] |
4.1.2 Children |
1 |
233 |
Odds Ratio (M‐H, Random, 95% CI) |
0.57 [0.33, 0.99] |
4.2 Resolution of symptoms post‐treatment (evaluable participants) |
3 |
602 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.62 [0.38, 1.01] |
4.2.1 Adults |
2 |
410 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.59 [0.31, 1.13] |
4.2.2 Children |
1 |
192 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.66 [0.32, 1.38] |
4.3 Incidence of relapse (evaluable participants) |
3 |
523 |
Odds Ratio (M‐H, Fixed, 95% CI) |
1.27 [0.64, 2.50] |
4.4 Adverse events (ITT analysis) |
3 |
795 |
Odds Ratio (M‐H, Random, 95% CI) |
1.08 [0.75, 1.55] |